Skip to main content
    A

    Alpha Teknova Inc (TKNO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $7.77
    -0.44 (-5.36%)

    Market Cap: $516.43M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Alpha Teknova Inc (TKNO) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Alpha Teknova (TKNO) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Alpha Teknova reported EPS of -$0.06, in line with the -$0.06 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    74%(17/23)
    Avg Surprise
    +3.33%

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.08
    Range-$0.09 - -$0.07
    10 analysts
    Revenue Consensus
    $11.29M
    Range$10.41M - $12.07M
    9 analysts
    Reports May 4, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.07
    Range-$0.08 - -$0.05
    6 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.08+13.3%
    60d ago-$0.08+13.3%
    30d ago-$0.07+9.7%
    7d ago-$0.07+9.7%
    Current-$0.07
    Revenue Consensus
    $12.40M
    Range$11.70M - $12.86M
    6 analysts

    Next Report

    TKNO has an expected report date of Feb 24, 2027.

    TKNO Earnings Call

    The latest TKNO earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 23 quarters below that had an estimate, TKNO beat 17, missed 4 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $12.70M, up 21.5% from $10.45M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.06-$0.06N/A0.00%In lineN/A44 up, 1 downNov 4, 2026$12.70M
    Jun 30, 2026-$0.06-$0.08N/A+25.00%BeatN/A10 up, 0 downAug 5, 2026$12.19M
    Mar 31, 2026-$0.08-$0.09-$0.10 - -$0.09+11.11%BeatN/A31 up, 2 downMay 6, 2026$11.08M
    Dec 31, 2025-$0.09-$0.09-$0.10 - -$0.080.00%In lineN/A50 up, 1 downFeb 26, 2026$9.98M
    Sep 30, 2025-$0.08-$0.09-$0.10 - -$0.08+11.11%BeatN/A41 up, 0 downNov 6, 2025$10.45M
    Jun 30, 2025-$0.07-$0.10N/A+29.72%BeatN/A10 up, 0 downAug 7, 2025$10.29M
    Mar 31, 2025-$0.09-$0.11N/A+18.18%BeatN/AN/A0 up, 0 downMay 8, 2025$9.79M
    Dec 31, 2024-$0.11-$0.12-$0.13 - -$0.11+8.33%BeatN/A41 up, 0 downMar 4, 2025$9.27M
    Sep 30, 2024-$0.15-$0.11-$0.14 - -$0.10-36.36%MissN/A40 up, 0 downNov 7, 2024$9.58M
    Jun 30, 2024-$0.13-$0.16-$0.17 - -$0.15+18.75%BeatN/A41 up, 0 downAug 13, 2024$9.61M
    Mar 31, 2024-$0.20-$0.25-$0.29 - -$0.22+20.00%BeatN/A40 up, 0 downMay 13, 2024$9.29M
    Dec 31, 2023-$0.21-$0.24-$0.32 - -$0.20+12.50%BeatN/A40 up, 0 downMar 11, 2024$7.87M
    Sep 30, 2023-$0.26-$0.27N/A+3.70%BeatN/A30 up, 0 downNov 9, 2023$8.17M
    Jun 30, 2023-$0.18-$0.28-$0.31 - -$0.26+35.71%BeatN/A40 up, 0 downAug 10, 2023$11.53M
    Mar 31, 2023-$0.31-$0.28-$0.33 - -$0.28-10.71%MissN/A20 up, 0 downMay 10, 2023$9.12M
    Dec 31, 2022-$0.47-$0.34-$0.35 - -$0.34-38.24%MissN/A20 up, 0 downMar 15, 2023$7.89M
    Sep 30, 2022-$0.22-$0.29-$0.32 - -$0.27+24.14%BeatN/A20 up, 0 downNov 9, 2022$10.69M
    Jun 30, 2022-$0.22-$0.25N/A+12.00%BeatN/AN/A0 up, 0 downAug 10, 2022$11.69M
    Mar 31, 2022-$0.20-$0.21N/A+4.76%BeatN/A10 up, 0 downMay 11, 2022$11.15M
    Dec 31, 2021-$0.11-$0.17-$0.20 - -$0.15+35.29%BeatN/A30 up, 0 downMar 15, 2022$10.11M
    Sep 30, 2021-$0.10-$0.12-$0.15 - -$0.11+16.67%BeatN/A4N/ANov 10, 2021$9.39M
    Jun 30, 2021-$0.45-$0.18-$0.27 - -$0.09-150.00%MissN/A4N/AAug 11, 2021$8.31M
    Mar 31, 2021-$0.03-$0.04N/A+25.00%BeatN/AN/AN/AJun 25, 2021$9.08M
    Dec 31, 2020-$0.34N/AN/AN/AN/A-526.4%N/AN/AMar 30, 2021$10.16M
    Dec 31, 2019$0.08N/AN/AN/AN/AN/AN/AN/AMar 30, 2020N/A
    Last 25 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.33, after -$0.59 the year before. It was $0.08 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.33N/A
    Dec 31, 2024-$0.59N/A
    Dec 31, 2023-$0.96N/A
    Dec 31, 2022-$1.11N/A
    Dec 31, 2021-$0.69N/A
    Dec 31, 2020-$0.34-526.4%
    Dec 31, 2019$0.08N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,300 words across 11 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20266,30811
    2026Q1Mar 31, 20263,9489
    2025Q4Dec 31, 20255,0468
    2025Q3Sep 30, 20254,3079
    2025Q2Jun 30, 20255,4159
    2025Q1Mar 31, 20254,9709
    2024Q3Sep 30, 20244,7258
    2024Q2Jun 30, 20245,1788

    2026Q3 Earnings Call

    Opening remarks

    Jennifer Henry Senior Vice President of Marketing Thank you, operator. Welcome to Teknova's Third Quarter 2026 Earnings Conference Call. With me on today's call are Stephen Gunstream, Teknova's President and Chief Executive Officer; and Matt Lowell, Teknova's Chief Financial Officer, who will make prepared remarks and then take your questions. As a reminder, the forward-looking statements that we make during this call, including those regarding business goals and expectations for the financial performance of the company, are subject to risks and uncertainties that may cause actual events or results to differ. Additional information concerning these risk factors is included in the press release the company issued earlier today, and they are more fully described in the company's various filings with the SEC. Today's comments reflect the company's current views, which could change as a result of new information, future events or other factors, and the company does not obligate or commit itself to update its forward-looking statements, except as required by law. The company's management believes that in addition to GAAP results, non-GAAP financial measures can provide meaningful insight when evaluating the company's financial performance and the effectiveness of its business strategies. We will therefore use non-GAAP financial measures of certain of our results during this call. Reconciliations of GAAP to non-GAAP financial measures are included in the press release that we issued this afternoon, which is posted to Teknova's website and at www.sec.gov/edgar. Non-GAAP financial measures should always be considered only as a supplement to and not as a substitute for or as superior to financial measures prepared in accordance with GAAP. The non-GAAP financial measures in this presentation may differ from similarly named non-GAAP financial measures used by other companies. Please also be advised that the company has posted a supplemental slide deck to accompany today's prepared remarks. It can be accessed on the Investor Relations section of Teknova's website and on today's webcast. And now, I will turn the call over to Stephen.

    Stephen Gunstream President and Chief Executive Officer Thank you, Jen. Good afternoon, and thank you, everyone, for joining us for our third quarter 2026 earnings call. As you saw in the press release, we delivered our second consecutive quarter of record revenue with 22% top-line growth compared to the same period last year. In addition to exceeding 20% growth for the first time in over 4 years, we are particularly encouraged that the growth came from sales of custom products to life science tools and diagnostics customers and, notably, to biopharma customers. We believe the recent acceleration of revenue growth from sales to biopharma customers is an early indication that we're benefiting from the increase in biotech funding that we've observed over the previous 4 quarters. Given this backdrop, we feel confident as we head into 2027.

    Frequently Asked Questions About TKNO

    When is Alpha Teknova's next earnings date?

    Alpha Teknova's next earnings report is expected for Feb 24, 2027.

    Did TKNO beat earnings estimates last quarter?

    Alpha Teknova reported EPS of -$0.06 for the quarter ended Sep 30, 2026, in line with the -$0.06 estimate.

    What EPS do analysts expect from TKNO next quarter?

    The consensus EPS estimate for Alpha Teknova for the quarter ending Dec 31, 2026 is -$0.08 from 10 analysts, with estimates from -$0.09 to -$0.07.

    How often does TKNO beat earnings estimates?

    Alpha Teknova beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +12.93%.